These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Kidney function in cyclosporine-treated pediatric heart transplant recipients. Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133 [TBL] [Abstract][Full Text] [Related]
3. The natural history of renal function following orthotopic heart transplant. Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562 [TBL] [Abstract][Full Text] [Related]
4. Renal outcome after ciclosporin-induced nephrotoxicity. Tostivint I; du Montcel ST; Jaudon MC; Mallet A; Le Hoang P; Bodaghi B; Deray G; Bagnis CI Nephrol Dial Transplant; 2007 Mar; 22(3):880-5. PubMed ID: 17127700 [TBL] [Abstract][Full Text] [Related]
5. Detailed study of changes in renal function after conversion from cyclosporine to azathioprine. Hilbrands LB; Hoitsma AG; Wetzels JF; Koene RA Clin Nephrol; 1996 Apr; 45(4):230-5. PubMed ID: 8861797 [TBL] [Abstract][Full Text] [Related]
6. Five years' follow-up of renal glomerular and tubular functions in heart transplant recipients. Hartmann A; Andereassen AK; Holdaas H; Simonsen S; Geiran O; Berg KJ J Heart Lung Transplant; 1996 Oct; 15(10):972-9. PubMed ID: 8913913 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
8. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus. Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511 [TBL] [Abstract][Full Text] [Related]
9. Effects of cyclosporin A withdrawal on renal function and renal stimulation in liver transplant patients treated with triple-drug immunosuppression for over 2 years. Klompmaker IJ; Homan van der Heide JJ; Tegzess AM; Meijer S; Haagsma EB; Verwer R; Slooff MJ Nephrol Dial Transplant; 1994; 9(11):1629-33. PubMed ID: 7870353 [TBL] [Abstract][Full Text] [Related]
10. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932 [TBL] [Abstract][Full Text] [Related]
11. An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing. Bunke M; Sloan R; Brier M; Ganzel B Transplantation; 1995 Feb; 59(4):537-40. PubMed ID: 7878758 [TBL] [Abstract][Full Text] [Related]
12. Effect of felodipine on renal haemodynamics and tubular sodium handling in cyclosporin-treated renal transplant recipients. Sørensen SS; Skovbon H; Eiskjaer H; Thomsen K; Pedersen EB Nephrol Dial Transplant; 1992; 7(1):69-78. PubMed ID: 1316584 [TBL] [Abstract][Full Text] [Related]
13. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies. Pedersen EB; Madsen JK; Sørensen SS; Zachariae H Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522 [TBL] [Abstract][Full Text] [Related]
14. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers. Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184 [TBL] [Abstract][Full Text] [Related]
15. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [TBL] [Abstract][Full Text] [Related]
16. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Kanbay M; Akcay A; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M Transplant Proc; 2005 Sep; 37(7):3119-20. PubMed ID: 16213325 [TBL] [Abstract][Full Text] [Related]
17. Fish oil and cyclosporin A-induced renal hypoperfusion in kidney-transplanted patients. Hansen JM; Høy CE; Strandgaard S Nephrol Dial Transplant; 1995; 10(9):1745-50. PubMed ID: 8559499 [TBL] [Abstract][Full Text] [Related]
18. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study. Oberbauer R; Kreis H; Johnson RW; Mota A; Claesson K; Ruiz JC; Wilczek H; Jamieson N; Henriques AC; Paczek L; Chapman J; Burke JT; Transplantation; 2003 Jul; 76(2):364-70. PubMed ID: 12883194 [TBL] [Abstract][Full Text] [Related]
19. Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year. Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Budde K; Waiser J; Luft FC Nephrol Dial Transplant; 1996 Jan; 11(1):165-72. PubMed ID: 8649628 [TBL] [Abstract][Full Text] [Related]
20. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]